Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alzheimer’s disease biomarker profiling in a memory clinic cohort without common comorbidities

1 Jan 2023

Abstract excerpt

Alzheimer's disease is a multifactorial disorder with large heterogeneity. Comorbidities such as hypertension, hypercholesterolaemia and diabetes are known contributors to disease progression. However, less is known about their mechanistic contribution to Alzheimer's pathology and neurodegeneration. The aim of this study was to investigate the relationship of several biomarkers related to risk mechanisms in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Health, Environment, Cognitive Aging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37680670
DOI: 10.1093/braincomms/fcad228

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alzheimer’s disease biomarker profiling in a memory clinic cohort without common comorbiditiesPMID 37680670Read ↗

Natural history of nonketotic hyperglycinemia in 65 patientsSemantic proximity Read ↗

Predictors of Cognitive Decline in Healthy Middle-Aged Individuals with Asymptomatic Alzheimer’s DiseaseSemantic proximity Read ↗

Cerebrospinal Fluid (CSF) Proteomic Signature in Preclinical and Clinical AD: Role of Adhesion Molecules.Semantic proximity Read ↗

Navigation Between Alzheimer’s Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology—Genetics and NeuroinflammationSemantic proximity Read ↗

Large-scale proteomic analyses of incident Alzheimer’s disease reveal new pathophysiological insights and potential therapeutic targetsSemantic proximity Read ↗

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panelsSemantic proximity Read ↗

Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read ↗

Blood biomarker profiles in young-onset neurocognitive disorders: A cohort studySemantic proximity Read ↗

Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort studySemantic proximity Read ↗

Identification of conserved proteomic networks in neurodegenerative dementiaSemantic proximity Read ↗

Serum proteomics reveals APOE dependent and independent protein signatures in Alzheimer’s diseaseSemantic proximity Read ↗

Spotlight on the Pathophysiological Trajectories Linked to Alzheimer’s Disease (AD): Blood-Brain Barrier (BBB); Neuroinflammation; APOE4 Allele and AD- Insulin Resistance (IR) Pathogenic LinkSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.